Regulatory rejection sparks Merck shares sell-off - Regulatory rejection sparks Merck shares sell-off Health / Medicine Related News Merck's shares tumbled after its results announcement and a regulatory blow for its Erbitux drug Source: FT.com - Pharmaceuticals Psychology, Special Needs & Health.